Aripiprazole may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Amlodipine is combined with Quinapril. The metabolism of Amlodipine can be decreased when combined with Cyclosporine. The serum concentration of Ubidecarenone can be increased when it is combined with Amlodipine. The metabolism of Amlodipine can be increased when combined with Lumacaftor. The risk or severity of adverse effects can be increased when Telmisartan is combined with Lisinopril. The risk or severity of adverse effects can be increased when Tolcapone is combined with Telmisartan. The risk or severity of adverse effects can be increased when Amlodipine is combined with Eprosartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with E-6201. The serum concentration of Amlodipine can be increased when it is combined with Ivacaftor. The risk or severity of adverse effects can be increased when Radicicol is combined with Amlodipine. Yohimbine may decrease the antihypertensive activities of Telmisartan. The serum concentration of Pazopanib can be increased when it is combined with Telmisartan. Telmisartan may increase the hypotensive activities of Unoprostone. The risk or severity of adverse effects can be increased when Amlodipine is combined with Carvedilol. The serum concentration of Amlodipine can be decreased when it is combined with Efavirenz. The risk or severity of adverse effects can be increased when Telmisartan is combined with Enalaprilat. Amlodipine may increase the hypotensive activities of Cyclothiazide. The risk or severity of adverse effects can be increased when Telmisartan is combined with Carprofen. The risk or severity of adverse effects can be increased when Telmisartan is combined with Droxicam. Tadalafil may increase the antihypertensive activities of Amlodipine. The serum concentration of Fosphenytoin can be increased when it is combined with Amlodipine. The serum concentration of Amlodipine can be decreased when it is combined with Bosentan. Iproniazid may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Naftifine is combined with Amlodipine. Tolvaptan may increase the hyperkalemic activities of Telmisartan. The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan. Telmisartan may increase the hypotensive activities of Sitaxentan. Telmisartan may increase the orthostatic hypotensive activities of Duloxetine. Amlodipine may increase the hypotensive activities of Rescinnamine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Enalapril. The risk or severity of adverse effects can be increased when Telmisartan is combined with Terazosin. Amlodipine may increase the hypotensive activities of Trichlormethiazide. The risk or severity of adverse effects can be increased when Telmisartan is combined with Isoxicam. Harmaline may increase the hypotensive activities of Telmisartan. Isocarboxazid may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Benoxaprofen. The risk or severity of adverse effects can be increased when Telmisartan is combined with Etoricoxib. Amlodipine may increase the hypotensive activities of Nilvadipine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Penbutolol. The risk or severity of adverse effects can be increased when Amlodipine is combined with Nesiritide. Pivhydrazine may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Hexetidine is combined with Amlodipine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Zomepirac. Caroxazone may increase the hypotensive activities of Amlodipine. Amlodipine may increase the hypotensive activities of Unoprostone. The risk or severity of adverse effects can be increased when Capric acid is combined with Amlodipine. The risk or severity of adverse effects can be increased when Ergonovine is combined with Amlodipine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Nafamostat. The risk or severity of adverse effects can be increased when Amlodipine is combined with Cilazapril. The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Telmisartan. The risk or severity of adverse effects can be increased when Haloprogin is combined with Amlodipine. Telmisartan may increase the hypotensive activities of Deserpidine. The risk or severity of adverse effects can be increased when Mevastatin is combined with Amlodipine. Amlodipine may increase the hypotensive activities of Lercanidipine. The risk or severity of adverse effects can be increased when Apomorphine is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Triptolide. The risk or severity of adverse effects can be increased when Nitroprusside is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Diclofenamide. The risk or severity of adverse effects can be increased when Telmisartan is combined with Guanfacine. Amlodipine may increase the hypotensive activities of Macitentan. Pentoxifylline may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Pirfenidone. The risk or severity of adverse effects can be increased when Telmisartan is combined with Bretylium. The risk or severity of adverse effects can be increased when Clofarabine is combined with Telmisartan. Telmisartan may increase the hypotensive activities of Vinpocetine. The risk or severity of adverse effects can be increased when Metoprolol is combined with Telmisartan. The risk or severity of adverse effects can be increased when Ramipril is combined with Amlodipine. Procarbazine may increase the hypotensive activities of Amlodipine. The serum concentration of Afatinib can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Zileuton. The risk or severity of adverse effects can be increased when Ropinirole is combined with Telmisartan. Rasagiline may increase the hypotensive activities of Telmisartan. The metabolism of Amlodipine can be decreased when combined with Telaprevir. The risk or severity of adverse effects can be increased when Betaxolol is combined with Telmisartan. The risk or severity of adverse effects can be increased when Clotrimazole is combined with Amlodipine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Nadolol. The serum concentration of Deslanoside can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Amlodipine is combined with Bendroflumethiazide. Latanoprost may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Amlodipine is combined with Mannitol. The risk or severity of adverse effects can be increased when Telmisartan is combined with Icatibant. Moxonidine may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Amlodipine is combined with Captopril. Tinzaparin may increase the hyperkalemic activities of Telmisartan. The risk or severity of adverse effects can be increased when Imidapril is combined with Amlodipine. Amobarbital may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Ergotamine is combined with Amlodipine. The serum concentration of the active metabolites of Artesunate can be reduced when Artesunate is used in combination with Amlodipine resulting in a loss in efficacy. The serum concentration of Ranolazine can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Miltefosine is combined with Amlodipine. Telmisartan may increase the hypotensive activities of Nilvadipine. Amlodipine may increase the hypotensive activities of Cicletanine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Salicylic acid. Udenafil may increase the antihypertensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Bufexamac. Dorzolamide may increase the hypotensive activities of Telmisartan. The metabolism of Amlodipine can be decreased when combined with Fluvoxamine. The risk or severity of adverse effects can be increased when Metergoline is combined with Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Verapamil. The risk or severity of adverse effects can be increased when Clozapine is combined with Amlodipine. Pargyline may increase the hypotensive activities of Amlodipine. Telmisartan may increase the hypotensive activities of Niguldipine. Bethanidine may increase the hypotensive activities of Amlodipine. Debrisoquin may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Butoconazole is combined with Amlodipine. Iproniazid may increase the hypotensive activities of Amlodipine. Methylene blue may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Torasemide is combined with Telmisartan. The risk or severity of adverse effects can be increased when Amlodipine is combined with Methyldopa. The risk or severity of adverse effects can be increased when Telmisartan is combined with SRT501. The serum concentration of Rosuvastatin can be increased when it is combined with Amlodipine. Travoprost may increase the hypotensive activities of Telmisartan. The serum concentration of Edoxaban can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Isoconazole is combined with Amlodipine. The serum concentration of Bosutinib can be increased when it is combined with Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Chlorothiazide. Hexobarbital may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Bifonazole is combined with Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Hydrochlorothiazide. The risk or severity of adverse effects can be increased when Telmisartan is combined with Indomethacin. Methylphenidate may decrease the antihypertensive activities of Telmisartan. Hydracarbazine may increase the hypotensive activities of Telmisartan. Indoramin may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Cilnidipine is combined with Telmisartan. The risk or severity of adverse effects can be increased when Griseofulvin is combined with Amlodipine. Mirodenafil may increase the antihypertensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Papaverine. The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium lactate. Nicorandil may increase the hypotensive activities of Amlodipine.